Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 EUR | +7.93% | +10.62% | +58.60% |
Apr. 16 | Finland’s Nightingale Health Plots US Expansion | MT |
Apr. 16 | Nightingale Health to Establish A Laboratory in the United States | CI |
Business Summary
Number of employees: 81
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health Data Platform
100.0
%
| 2 | 100.0 % | 4 | 100.0 % | +89.66% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
56.5
%
| - | - | 2 | 56.5 % | - |
Rest of Europe
24.7
%
| - | - | 1 | 24.7 % | - |
Others
13.5
%
| - | - | 1 | 13.5 % | - |
Finland
5.3
%
| 2 | 100.0 % | 0 | 5.3 % | -89.98% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Würtz
FOU | Founder | - | 01-12-31 |
Satu Saksman
FOU | Founder | 48 | 01-12-31 |
Pasi Soininen
FOU | Founder | - | 01-12-31 |
Founder | 40 | 01-12-31 | |
Founder | 42 | 01-12-31 | |
Tuukka Paavola
DFI | Director of Finance/CFO | 44 | 21-12-06 |
Salla Ruosaari
CTO | Chief Tech/Sci/R&D Officer | 48 | 16-12-31 |
Jeffrey Barrett
CTO | Chief Tech/Sci/R&D Officer | 44 | 21-09-26 |
Corporate Officer/Principal | 47 | 23-07-31 | |
Minja Salmio
LAW | General Counsel | 37 | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-12-16 | |
Chairman | 61 | 20-12-31 | |
Olli Pekka Karhi
BRD | Director/Board Member | 61 | 14-12-31 |
Director/Board Member | 47 | 22-12-31 | |
Founder | 42 | 01-12-31 | |
Founder | 40 | 01-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,178,565 | 0 | 577,920 ( 49.04 %) | 53.93 % |
Stock B | 1 | 20,585,924 | 0 | 0 | |
Stock C | 1 | 39,233,735 | 32,895,474 ( 83.84 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
NIGHTINGALE HEALTH OYJ 38.98% | 577,920 | 38.98% | 1,106,116 $ |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.60% | 107M | |
+8.68% | 33.82B | |
+19.82% | 7.85B | |
+30.70% | 4.28B | |
-30.43% | 2.64B | |
-26.60% | 1.3B | |
-34.43% | 1.14B | |
+10.41% | 987M | |
-35.57% | 901M | |
-21.37% | 696M |
- Stock Market
- Equities
- HEALTH Stock
- Company Nightingale Health Oyj